| Wage Level | Filings | Avg Salary |
|---|---|---|
| Level IV | 2 | $300,000 |
Vyluma Inc.'s H1B filings are predominantly senior-level, with Level IV (Fully Competent) accounting for 100% of all wage level certifications at an average of $300,000. Levels III and IV together account for 100% of all filings, reinforcing the senior-weighted hiring profile. Higher wage levels carry statistically lower USCIS denial rates, which helps explain Vyluma Inc.'s strong overall approval record.
| # | Job Title | Filings | Avg Salary | Year |
|---|---|---|---|---|
| 1 | Vice President, Ophthalmic New Drug Development | 2 | $300,000 | FY2023 |
Vyluma Inc. sponsors a narrow set of roles under H1B, with Vice President, Ophthalmic New Drug Development ranking as the most-filed title at an average LCA salary of $300,000 (100% of filings shown). Filing volume is heavily concentrated in one title, suggesting a focused, specialist H1B program.
The average H1B LCA-certified salary at Vyluma Inc. is $300,000 based on US Department of Labor public disclosure data. This reflects the wage employers legally committed to pay at time of filing. Actual salaries vary by role, location, and experience level.
The most commonly sponsored role at Vyluma Inc. is Vice President, Ophthalmic New Drug Development with an average salary of $300,000. See the full job title breakdown above for min, avg, and max salaries across all roles.
DOL wage levels range from Level I (entry-level, 17th percentile) to Level IV (expert, 67th percentile). Higher wage levels carry lower USCIS denial risk. The wage level breakdown for Vyluma Inc. is shown in the table above.
Yes. All figures come from the US Department of Labor public LCA disclosure dataset. Employers are legally required to pay at or above the certified wage for each H1B worker. The data is not estimated or self-reported.
Vyluma Inc. has a 100.0% USCIS H1B approval rate. This is above the national average, indicating a reliable sponsorship record.